Insider Trading & Ownership of Melissa B. Epperly

Location: Philadelphia, PA
Summary: The estimated net worth of Melissa B. Epperly is at least $5,617,835 dollars as of 18 Mar 2026. Melissa B. Epperly is the Chief Financial Officer of Zentalis Pharmaceuticals, Inc. and owns shares of Zentalis Pharmaceuticals, Inc. (ZNTL) stock worth about $5.16M. Melissa B. Epperly is the Director of Roivant Sciences Ltd. and owns shares of Roivant Sciences Ltd. (ROIV) stock worth about $453.3K.
Signature: By: /s/ Jo Chen, as Attorney-in-Fact for Melissa B. Epperly
All Insider Reports: All Insider Reports

Notify me when Melissa B. Epperly files a new Insider Trading report.

Ownership of Melissa B. Epperly

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
ZNTL	Zentalis Pharmaceuticals, Inc.	Chief Financial Officer	$5,164,577			12 Feb 2024
ROIV	Roivant Sciences Ltd.	Director	$453,258	-$1,200,573	-73%	16 Mar 2026
KNTE	Kinnate Biopharma Inc.	Director				03 Apr 2024
NAUT	Nautilus Biotechnology, Inc.	Director				23 Jun 2025

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.